BioNTech SE
BNTX
$96.19
-$1.08-1.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -812.62M | -717.13M | -500.78M | -543.77M | 118.45M |
| Total Depreciation and Amortization | 323.87M | 320.41M | 228.93M | 225.07M | 206.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -405.26M | -700.03M | -349.75M | -155.93M | -350.64M |
| Change in Net Operating Assets | 627.61M | 1.31B | 2.24B | 3.68B | 6.26B |
| Cash from Operations | -266.41M | 210.70M | 1.62B | 3.21B | 6.23B |
| Capital Expenditure | -297.85M | -309.90M | -329.01M | -307.75M | -285.54M |
| Sale of Property, Plant, and Equipment | 1.82M | 1.29M | 545.10K | 215.30K | -- |
| Cash Acquisitions | -82.61M | -- | 0.00 | -366.69M | -366.69M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.92B | -1.96B | -5.49B | -6.33B | -8.59B |
| Cash from Investing | 1.54B | -2.27B | -5.82B | -7.00B | -9.24B |
| Total Debt Issued | -- | -- | 200.00K | 300.00K | 300.00K |
| Total Debt Repaid | -51.90M | -45.90M | -50.90M | -52.40M | -38.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -800.00K | -302.50M | -456.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -55.64M | -49.58M | -55.69M | -385.50M | -538.71M |
| Foreign Exchange rate Adjustments | -8.53M | 15.80M | -149.20M | -80.06M | 22.76M |
| Miscellaneous Cash Flow Adjustments | 59.47M | 3.45M | 194.09M | 151.10M | 107.51M |
| Net Change in Cash | 1.27B | -2.09B | -4.21B | -4.11B | -3.42B |